Search Results - xiulei+mo

3 Results Sort By:
Precision Neo-Cysteine Molecular Glues to Restore Protein-Protein Interactions in Disease
Application Molecular glues designed to selectively bind mutated neo-cysteine residues and restore disease-disrupted protein–protein interactions (PPIs), offering a precision therapeutic approach for conditions such as cancer where loss or weakening of critical protein interactions drives tumor growth and progression. Key Benefits Provides...
Published: 3/23/2026   |   Updated: 2/25/2026   |   Inventor(s): Xiulei Mo, Haian Fu
Keywords(s): Oncology Treatments, Personalized Medicine, Protein and Peptide Therapeutics, Therapeutics
Category(s): TechPub Algolia > Drug Discovery
HTiP: High-Throughput Immunomodulator Phenotypic Screening Platform
­ Application High Throughput Screening for identifying effective immuno-modulators. Key Benefits HT screening platform replicating complex immune medicated response to facilitate discovery of small molecule immunomodulatory agents. Simplicity and dual readouts of the design enable the screening of large chemical libraries to identify compounds...
Published: 1/20/2026   |   Updated: 5/17/2022   |   Inventor(s): Xiulei Mo, Haian Fu
Keywords(s): Immunoassays, Platform
Category(s): TechPub Algolia > Drug Discovery, TechPub Algolia > Research Tools
Targeted Immunotherapy for KRAS-Driven Cancers
Application Targeted immunotherapy and companion biosensing approach for cancers harboring the KRASG12V mutation. Key Benefits First-in-class therapeutic strategy specifically designed for KRASG12V-positive cancers. Addresses a significant unmet need in oncology where no approved KRASG12V-targeted therapies currently exist. Restores the body’s...
Published: 3/23/2026   |   Updated: 1/7/2022   |   Inventor(s): Haian Fu, Cong Tang, Xiulei Mo
Keywords(s): Drug Target Identification, Enzyme and Protein Research, Immunology and Inflammation Treatments, Oncology Treatments
Category(s): TechPub Algolia > Drug Discovery, TechPub Algolia > Therapeutics